8.8 C
New York
Sunday, November 24, 2024
HomeIndia NewsTop Indian ministers in hospital as virus cases breach 50,000 for fifth day

Top Indian ministers in hospital as virus cases breach 50,000 for fifth day

Date:

Related stories

Indian top court censures Delhi government over pollution control delays

Delhi’s pollution levels worsened Monday, with an AQI of...

Security tightened in Ayodhya after threat to Ram Temple by pro-Khalistan leader

In response to an alleged threat by pro-Khalistan leader...

Eleven militants killed in Manipur gunfight, CRPF personnel injured

A gunfight between security forces and militants in Manipur’s...

Three terrorists killed in attack on army convoy in Jammu and Kashmir

Security forces killed two terrorists on Tuesday morning following...

India‘s interior minister and the chiefs of two big states have been hospitalized with COVID-19 as the country’s daily cases topped 50,000 for a fifth straight day on Monday.

The country reported 52,972 new confirmed infections in the past 24 hours, taking the total to 1.8 million – the third highest in the world after the United States and Brazil – data from India‘s Ministry of Health and Family Welfare showed on Monday.

With 771 new deaths, the COVID-19 disease has now killed 38,135 people in India, including that of a minister on Sunday in the most-populous state of Uttar Pradesh.

On Sunday, federal interior minister Amit Shah, one of Prime Minister Narendra Modi’s closest aides, as well as the chief minister of the southern state of Karnataka, were hospitalised. The chief of the central state of Madhya Pradesh is also recovering in hospital.

It was not immediately clear whether Shah’s cabinet colleagues, including the finance minister, had isolated themselves.

- Advertisement -

As infections continue to surge in the country, having registered a record of 57,118 on Saturday, India has also stepped up efforts to test more people and search for a vaccine.

The health ministry said on Twitter that the country’s drugs authorities had allowed Serum Institute of India, the world’s largest manufacturer of vaccines by volume, to conduct clinical trials of a vaccine candidate developed by Oxford University and AstraZeneca Plc.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories